Selected research
Market Structure
Global Dry Eye Therapy Eye Drops Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Dry Eye Therapy Eye Drops market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Dry Eye Therapy Eye Drops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Dry Eye Therapy Eye Drops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dry Eye Therapy Eye Drops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Dry Eye Therapy Eye Drops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Dry Eye Therapy Eye Drops include Novartis, Rohto, CooperVision, Santen Pharma, Alcon, AbbVie, Zhenshiming, URSAPHARM and Thea pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Dry Eye Therapy Eye Drops market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Dry Eye Therapy Eye Drops and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Dry Eye Therapy Eye Drops sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dry Eye Therapy Eye Drops market size, projected growth trends, production technologies, key applications, and end-use industries.
Dry Eye Therapy Eye Drops Segment by Company
Novartis
Rohto
CooperVision
Santen Pharma
Alcon
AbbVie
Zhenshiming
URSAPHARM
Thea pharmaceuticals
Prestige Consumer Healthcare
OmniVision Pharma
LION
Kenvue (VISINE)
Bausch Health
Dry Eye Therapy Eye Drops Segment by Type
Sodium Hyaluronate Eye Drops
Sodium Carboxymethylcellulose Eye Drops
Other
Dry Eye Therapy Eye Drops Segment by Application
Middle Age
Teenagers
Older Adult
Dry Eye Therapy Eye Drops Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Therapy Eye Drops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Therapy Eye Drops and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Therapy Eye Drops.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dry Eye Therapy Eye Drops market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Eye Therapy Eye Drops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Eye Therapy Eye Drops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dry Eye Therapy Eye Drops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Sodium Hyaluronate Eye Drops
- Sodium Carboxymethylcellulose Eye Drops
- Other
Applications
- Middle Age
- Teenagers
- Older Adult
Companies covered
- Novartis
- Rohto
- CooperVision
- Santen Pharma
- Alcon
- AbbVie
- Zhenshiming
- URSAPHARM
- Thea pharmaceuticals
- Prestige Consumer Healthcare
- OmniVision Pharma
- LION
- Kenvue (VISINE)
- Bausch Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Dry Eye Therapy Eye Drops Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Dry Eye Therapy Eye Drops Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Dry Eye Therapy Eye Drops Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Dry Eye Therapy Eye Drops Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Dry Eye Therapy Eye Drops Market Dynamics
- 2.1 Dry Eye Therapy Eye Drops Industry Trends
- 2.2 Dry Eye Therapy Eye Drops Industry Drivers
- 2.3 Dry Eye Therapy Eye Drops Industry Opportunities and Challenges
- 2.4 Dry Eye Therapy Eye Drops Industry Restraints
3 Dry Eye Therapy Eye Drops Market by Manufacturers
- 3.1 Global Dry Eye Therapy Eye Drops Revenue by Manufacturers (2021-2026)
- 3.2 Global Dry Eye Therapy Eye Drops Sales by Manufacturers (2021-2026)
- 3.3 Global Dry Eye Therapy Eye Drops Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Dry Eye Therapy Eye Drops Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Dry Eye Therapy Eye Drops Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Dry Eye Therapy Eye Drops Manufacturers, Product Type & Application
- 3.7 Global Dry Eye Therapy Eye Drops Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dry Eye Therapy Eye Drops Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dry Eye Therapy Eye Drops Players Market Share by Revenue in 2025
- 3.8.3 2025 Dry Eye Therapy Eye Drops Tier 1, Tier 2, and Tier 3
4 Dry Eye Therapy Eye Drops Market by Type
- 4.1 Dry Eye Therapy Eye Drops Type Introduction
- 4.1.1 Sodium Hyaluronate Eye Drops
- 4.1.2 Sodium Carboxymethylcellulose Eye Drops
- 4.1.3 Other
- 4.2 Global Dry Eye Therapy Eye Drops Sales by Type
- 4.2.1 Global Dry Eye Therapy Eye Drops Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Dry Eye Therapy Eye Drops Sales by Type (2021-2032)
- 4.2.3 Global Dry Eye Therapy Eye Drops Sales Market Share by Type (2021-2032)
- 4.3 Global Dry Eye Therapy Eye Drops Revenue by Type
- 4.3.1 Global Dry Eye Therapy Eye Drops Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Dry Eye Therapy Eye Drops Revenue by Type (2021-2032)
- 4.3.3 Global Dry Eye Therapy Eye Drops Revenue Market Share by Type (2021-2032)
5 Dry Eye Therapy Eye Drops Market by Application
- 5.1 Dry Eye Therapy Eye Drops Application Introduction
- 5.1.1 Middle Age
- 5.1.2 Teenagers
- 5.1.3 Older Adult
- 5.2 Global Dry Eye Therapy Eye Drops Sales by Application
- 5.2.1 Global Dry Eye Therapy Eye Drops Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Dry Eye Therapy Eye Drops Sales by Application (2021-2032)
- 5.2.3 Global Dry Eye Therapy Eye Drops Sales Market Share by Application (2021-2032)
- 5.3 Global Dry Eye Therapy Eye Drops Revenue by Application
- 5.3.1 Global Dry Eye Therapy Eye Drops Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Dry Eye Therapy Eye Drops Revenue by Application (2021-2032)
- 5.3.3 Global Dry Eye Therapy Eye Drops Revenue Market Share by Application (2021-2032)
6 Global Dry Eye Therapy Eye Drops Sales by Region
- 6.1 Global Dry Eye Therapy Eye Drops Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Dry Eye Therapy Eye Drops Sales by Region (2021-2032)
- 6.2.1 Global Dry Eye Therapy Eye Drops Sales by Region (2021-2026)
- 6.2.2 Global Dry Eye Therapy Eye Drops Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Dry Eye Therapy Eye Drops Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Dry Eye Therapy Eye Drops Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Dry Eye Therapy Eye Drops Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Dry Eye Therapy Eye Drops Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Dry Eye Therapy Eye Drops Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Dry Eye Therapy Eye Drops Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Dry Eye Therapy Eye Drops Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Dry Eye Therapy Eye Drops Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Dry Eye Therapy Eye Drops Revenue by Region
- 7.1 Global Dry Eye Therapy Eye Drops Revenue by Region
- 7.1.1 Global Dry Eye Therapy Eye Drops Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Dry Eye Therapy Eye Drops Revenue by Region (2021-2026)
- 7.1.3 Global Dry Eye Therapy Eye Drops Revenue by Region (2027-2032)
- 7.1.4 Global Dry Eye Therapy Eye Drops Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Dry Eye Therapy Eye Drops Revenue (2021-2032)
- 7.2.2 North America Dry Eye Therapy Eye Drops Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Dry Eye Therapy Eye Drops Revenue (2021-2032)
- 7.3.2 Europe Dry Eye Therapy Eye Drops Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Dry Eye Therapy Eye Drops Revenue (2021-2032)
- 7.4.2 Asia-Pacific Dry Eye Therapy Eye Drops Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Dry Eye Therapy Eye Drops Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Dry Eye Therapy Eye Drops Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Information
- 8.1.2 Novartis Business Overview
- 8.1.3 Novartis Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Novartis Dry Eye Therapy Eye Drops Product Portfolio
- 8.1.5 Novartis Recent Developments
- 8.2 Rohto
- 8.2.1 Rohto Company Information
- 8.2.2 Rohto Business Overview
- 8.2.3 Rohto Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Rohto Dry Eye Therapy Eye Drops Product Portfolio
- 8.2.5 Rohto Recent Developments
- 8.3 CooperVision
- 8.3.1 CooperVision Company Information
- 8.3.2 CooperVision Business Overview
- 8.3.3 CooperVision Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 CooperVision Dry Eye Therapy Eye Drops Product Portfolio
- 8.3.5 CooperVision Recent Developments
- 8.4 Santen Pharma
- 8.4.1 Santen Pharma Company Information
- 8.4.2 Santen Pharma Business Overview
- 8.4.3 Santen Pharma Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Santen Pharma Dry Eye Therapy Eye Drops Product Portfolio
- 8.4.5 Santen Pharma Recent Developments
- 8.5 Alcon
- 8.5.1 Alcon Company Information
- 8.5.2 Alcon Business Overview
- 8.5.3 Alcon Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Alcon Dry Eye Therapy Eye Drops Product Portfolio
- 8.5.5 Alcon Recent Developments
- 8.6 AbbVie
- 8.6.1 AbbVie Company Information
- 8.6.2 AbbVie Business Overview
- 8.6.3 AbbVie Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 AbbVie Dry Eye Therapy Eye Drops Product Portfolio
- 8.6.5 AbbVie Recent Developments
- 8.7 Zhenshiming
- 8.7.1 Zhenshiming Company Information
- 8.7.2 Zhenshiming Business Overview
- 8.7.3 Zhenshiming Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Zhenshiming Dry Eye Therapy Eye Drops Product Portfolio
- 8.7.5 Zhenshiming Recent Developments
- 8.8 URSAPHARM
- 8.8.1 URSAPHARM Company Information
- 8.8.2 URSAPHARM Business Overview
- 8.8.3 URSAPHARM Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 URSAPHARM Dry Eye Therapy Eye Drops Product Portfolio
- 8.8.5 URSAPHARM Recent Developments
- 8.9 Thea pharmaceuticals
- 8.9.1 Thea pharmaceuticals Company Information
- 8.9.2 Thea pharmaceuticals Business Overview
- 8.9.3 Thea pharmaceuticals Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Thea pharmaceuticals Dry Eye Therapy Eye Drops Product Portfolio
- 8.9.5 Thea pharmaceuticals Recent Developments
- 8.10 Prestige Consumer Healthcare
- 8.10.1 Prestige Consumer Healthcare Company Information
- 8.10.2 Prestige Consumer Healthcare Business Overview
- 8.10.3 Prestige Consumer Healthcare Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Prestige Consumer Healthcare Dry Eye Therapy Eye Drops Product Portfolio
- 8.10.5 Prestige Consumer Healthcare Recent Developments
- 8.11 OmniVision Pharma
- 8.11.1 OmniVision Pharma Company Information
- 8.11.2 OmniVision Pharma Business Overview
- 8.11.3 OmniVision Pharma Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 OmniVision Pharma Dry Eye Therapy Eye Drops Product Portfolio
- 8.11.5 OmniVision Pharma Recent Developments
- 8.12 LION
- 8.12.1 LION Company Information
- 8.12.2 LION Business Overview
- 8.12.3 LION Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 LION Dry Eye Therapy Eye Drops Product Portfolio
- 8.12.5 LION Recent Developments
- 8.13 Kenvue (VISINE)
- 8.13.1 Kenvue (VISINE) Company Information
- 8.13.2 Kenvue (VISINE) Business Overview
- 8.13.3 Kenvue (VISINE) Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Kenvue (VISINE) Dry Eye Therapy Eye Drops Product Portfolio
- 8.13.5 Kenvue (VISINE) Recent Developments
- 8.14 Bausch Health
- 8.14.1 Bausch Health Company Information
- 8.14.2 Bausch Health Business Overview
- 8.14.3 Bausch Health Dry Eye Therapy Eye Drops Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Bausch Health Dry Eye Therapy Eye Drops Product Portfolio
- 8.14.5 Bausch Health Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Dry Eye Therapy Eye Drops Value Chain Analysis
- 9.1.1 Dry Eye Therapy Eye Drops Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Dry Eye Therapy Eye Drops Production Mode & Process
- 9.2 Dry Eye Therapy Eye Drops Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Dry Eye Therapy Eye Drops Distributors
- 9.2.3 Dry Eye Therapy Eye Drops Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst